Skip to main content

Advertisement

Log in

Cognitive outcome as part and parcel of clinical outcome in brain tumor surgery

  • Effects of Standard of Art Treatment
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Although validated tools (neuropsychological tests, patient reported outcomes, mood and psychological profile) were first introduced many years ago in clinical practice, the impact of the tumor itself on patient cognition has not been extensively studied. Furthermore, while outcome research is evolving in an attempt to adapt the use of different tools to the preoperative and postoperative phases, the standard guidelines for evaluating outcome after brain surgery, by neurological examination and complication assessment, are frequently neglected in the current literature. This article attempts to provide an appraisal of the evidence for the impact of surgical treatment on cognitive function of brain tumor patients within the context of general outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Duffau H, Capelle L, Sichez N, Denvil D, Lopes M, Sichez JP, Bitar A, Fohanno D (2002) Intraoperative mapping of the subcortical language pathways using direct stimulation. An anatomo-functional study. Brain 125:199–214

    Article  PubMed  Google Scholar 

  2. Duffau H, Lopes M, Arthuis F, Bitar A, Sichez JP, Van Effenterre R, Capelle L (2005) Contribution of intraoperative electrical stimulation in surgery of low-grade gliomas: a comparative study between two series without (1985–1996) and with (1996–2003) functional mapping in the same situation. J Neurol Neurosurg Psychiatry 76:845–851

    Article  PubMed  CAS  Google Scholar 

  3. Buckner JC (2003) Factors influencing survival in high-grade gliomas. Semin Oncol 30(Suppl 19):10–14

    Article  PubMed  Google Scholar 

  4. Compostella A, Tosoni A, Blatt V, Franceschi E, Brandes AA (2007) Prognostic factors for anaplastic astrocytomas. J Neurooncol 81:295–303

    Article  PubMed  CAS  Google Scholar 

  5. Karnofsky DA, Burcheral JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: McLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 191–205

    Google Scholar 

  6. Meyers CA, Brown PD (2006) Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol 24:1305–1309

    Article  PubMed  Google Scholar 

  7. Mauer ME, Bottomley A, Taphoorn MJ (2008) Evaluating health-related quality of life and symptom burden in brain tumour patients: instruments for use in experimental trials and clinical practice. Curr Opin Neurol 21:745–753

    Article  PubMed  Google Scholar 

  8. Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA (1995) The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 75:1151–1161

    Article  PubMed  CAS  Google Scholar 

  9. Osoba D, Aaronson NK, Muller M et al (1996) The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res 5:139–150

    Article  PubMed  CAS  Google Scholar 

  10. Gotay CC, Kawamoto CT, Bottomley A, Efficace F (2008) The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 26:1355–1363

    Article  PubMed  Google Scholar 

  11. Weitzner MA, Meyers CA, Byrne K (1996) Psychosocial functioning and quality of life in patients with primary brain tumors. J Neurosurg 84:29–34

    Article  PubMed  CAS  Google Scholar 

  12. Sanai N, Mirzadeh Z, Berger MS (2008) Functional outcome after language mapping for glioma resection. N Engl J Med 358:18–27

    Article  PubMed  CAS  Google Scholar 

  13. Chang SM, Parney IF, McDermott M, Barker FG 2nd, Schmidt MH, Huang W, Laws ER Jr, Lillehei KO et al (2003) Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg 98:1175–1181

    Article  PubMed  Google Scholar 

  14. Chang S, Vogelbaum M, Lang FF, Haines S, Kunwar S, Chiocca EA, Olivi A, Quinones-Hinojosa A, Parsa A, Warnick R (2007) GNOSIS: guidelines for neuro-oncology: standards for investigational studies—reporting of surgically based therapeutic clinical trials. J Neuroncol 82:211–220

    Article  Google Scholar 

  15. Taphoorn MJ, Heimans JJ, Snoek FJ, Lindeboom J, Oosterink B, Wolberg JG, Karim ABM (1992) Assessment of quality of life in patients treated for low-grade glioma: a preliminary report. J Neurol Neurosurg Psychiatry 55:372–376

    Article  PubMed  CAS  Google Scholar 

  16. Taphoorn MJ, Stupp R, Coens C, Osoba D, Kortmann R, Van Den Bent MJ, Mason W, Mirimanoff RO et al (2005) Health related quality of life in patients with glioblastoma: a randomised clinical trial. Lancet Oncol 6:937–944

    Article  PubMed  Google Scholar 

  17. Giovagnoli AR, Boiardi A (1994) Cognitive impairment and quality of life in long-term survivors of malignant brain tumors. Ital J Neurol Sci 15:481–488

    Article  PubMed  CAS  Google Scholar 

  18. Buckner JC, Schomberg PJ, McGinnis WL, Cascino TL, Scheithauer BW, O’Fallon JR, Morton RF, Kuross SA et al (2001) A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma. Cancer 92:420–433

    Article  PubMed  CAS  Google Scholar 

  19. Liu R, Page M, Solheim K, Fox S, Chang SM (2009) Quality of life in adults with brain tumors: current knowledge and future directions. Neuro-oncology 11:330–339

    Article  PubMed  Google Scholar 

  20. Giovagnoli AR, Silvani A, Colombo E, Boiardi A (2005) Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry 76:562–568

    Article  PubMed  CAS  Google Scholar 

  21. Pålson A, Ek L, Ahlström G, Smita A (2003) Pitfalls in the assessment of disability in individuals with low-grade gliomas. J Neurooncol 65:149–158

    Article  Google Scholar 

  22. Taphoorn MJ, Klein M (2004) Cognitive deficits in adult patients with brain tumors. Lancet Neurol 3:159–168

    Article  PubMed  Google Scholar 

  23. World Health Organization (2001) International classification of functioning, disability, and health. World Health Organization, Geneva

    Google Scholar 

  24. Stummer W, Pichlmaier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol 7:392–401

    Article  PubMed  CAS  Google Scholar 

  25. Phillips C, Guiney M, Smith J, Hughes P, Narayan K, Quong G (2003) A randomized trial comparing 35 Gy in ten fractions with 60 Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma. Radiother Oncol 68:23–26

    Article  PubMed  Google Scholar 

  26. Roa W, Brasher PM, Bauman G et al (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22:1583–1588

    Article  PubMed  CAS  Google Scholar 

  27. Keime-Guibert F, Chinot O, Taillandier L et al (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527–1535

    Article  PubMed  CAS  Google Scholar 

  28. Levin VA, Phuphanich S, Yung WK et al (2006) Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation. J Neurooncol 78:295–302

    Article  PubMed  CAS  Google Scholar 

  29. Henriksson R, Malmstrom A, Bergstrom P et al (2006) High-grade astrocytoma treated concomitantly with estramustine and radiotherapy. J Neurooncol 78:321–326

    Article  PubMed  Google Scholar 

  30. Souhami L, Seiferheld W, Brachman D et al (2004) Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93–05 protocol. Int J Radiat Oncol Biol Phys 60:853–860

    Article  PubMed  Google Scholar 

  31. Cheng J, Zhang X, Liu BL (2009) Health-related quality of life in patients with high-grade glioma. Neuro-oncology 11:41–50

    Article  PubMed  Google Scholar 

  32. Efficace F, Bottomley A (2002) Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients. Eur J Cancer 38:1824–1831

    Article  PubMed  CAS  Google Scholar 

  33. Yung WK, Albright RE, Olson J et al (2000) A phase II study of temozolomide versus procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83:588–593

    Article  PubMed  CAS  Google Scholar 

  34. Trojanowski T, Peszynski J, Turowski K et al (1989) Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy. J Neurosurg 70:18–23

    Article  PubMed  CAS  Google Scholar 

  35. Pickles T, Goodman GB, Rheaume DE et al (1997) Pion radiation for high grade astrocytoma: results of a randomized study. Int J Radiat Oncol Biol Phys 37:491–497

    Article  PubMed  CAS  Google Scholar 

  36. Bampoe J, Laperriere N, Pintilie M, Glen J, Micallef J, Bernstein M (2000) Quality of life in patients with glioblastoma multiforme participating in a randomized study of brachytherapy as a boost treatment. J Neurosurg 93:917–926

    Article  PubMed  CAS  Google Scholar 

  37. Kiebert GM, Curran D, Aaronson NK et al (1998) Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group. Eur J Cancer 34:1902–1909

    Article  PubMed  CAS  Google Scholar 

  38. Mintz A, Perry J, Spithoff K, Chambers A, Lapierre N (2007) Management of single brain metastasis: a practice guideline. Curr Oncol 14:131–143

    Article  PubMed  CAS  Google Scholar 

  39. Signorelli F, Guyotat J, Isnard J, Schneider F, Mohammedi R, Bret P (2001) The value of cortical stimulation applied to the surgery of malignant gliomas in language areas. Neurol Sci 22:3–10

    Article  PubMed  CAS  Google Scholar 

  40. Fb Meyer, Bates LM, Goerss SJ, Friedman JA, Windschitl WL, Duffy JR, Perkins WJ, O’Neill BP (2001) Awake craniotomy for aggressive resection of primary gliomas located in eloquent brain. Mayo Clin Proc 76:677–687

    Article  Google Scholar 

  41. Haglund MM, Berger MS, Shamseldin M, Lettich E, Ojemann GA (1994) Cortical localization of temporal lobe language sites in patients with gliomas. Neurosurgery 34:567–576

    Article  PubMed  CAS  Google Scholar 

  42. Bello L, Gallucci M, Fava M, Carrabba G, Giussani C, Acerbi F, Baratta P, Songa V et al (2007) Intraoperative subcortical language tract mapping guides surgical removal for gliomas involving speech areas. Neurosurgery 60:67–80

    Article  PubMed  Google Scholar 

  43. Duffau H, Capelle L, Denvil D, Sichez N, Gatignol P, Taillandier L, Lopes M, Mitchell MC et al (2003) Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: functional results in a consecutive series of 103 patients. J Neurosurg 98:764–778

    Article  PubMed  Google Scholar 

  44. Medical Research Council (1981) Aids to the examination of the peripheral nervous system. Memorandum no. 45. Her Majesty’s Stationery Office, London

  45. House JW, Brackmann DE (1985) Facial nerve grading system. Otolaryngol Head Neck Surg 93:146–147

    PubMed  CAS  Google Scholar 

  46. Gardner G, Robertson JH (1988) Hearing preservation in unilateral acoustic neuroma surgery. Ann Otol Rhinol Laryngol 97:55–66

    PubMed  CAS  Google Scholar 

  47. Klein M, Taphoorn MJ, Heimans JJ et al (2001) Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol 19:4037–4047

    PubMed  CAS  Google Scholar 

  48. Brown PD, Maurer MJ, Rummans TA et al (2005) A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery 57:495–504

    Article  PubMed  Google Scholar 

  49. Klein M, Heimans JJ, Aaronson NK et al (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360:1361–1368

    Article  PubMed  CAS  Google Scholar 

  50. Litofsky NS, Farace E, Anderson F Jr, Meyers CA, Huang W, Laws ER Jr (2004) Depression in patients with high-grade glioma: results of the Glioma Outcome Project. Neurosurgery 54:358–367

    Article  PubMed  Google Scholar 

  51. Costello A, Shallice T, Gullan R, Beaney R (2004) The early effects of radiotherapy on intellectual and cognitive functioning in patients with frontal brain tumors: the use of a new neuropsychological methodology. J Neurooncol 67:351–359

    Article  PubMed  Google Scholar 

  52. Hahn CA, Dunn RH, Logue PE, King JH, Edwards CL, Halperin EC (2003) Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys 55:992–999

    Article  PubMed  CAS  Google Scholar 

  53. Gustafsson M, Edvardsson T, Ahlstrom G (2006) The relationship between function, quality of life and coping in patients with low-grade gliomas. Support Care Cancer 14:1205–1212

    Article  PubMed  Google Scholar 

  54. Tucha O, Smely C, Preier M, Lange KW (2000) Cognitive deficits before treatment among patients with brain tumors. Neurosurgery 47:324–333

    Article  PubMed  CAS  Google Scholar 

  55. Talacchi A, Santini B, Savazzi S, Gerosa M (2010) Cognitive effect of tumor and surgical treatment in glioma patients. J Neuroncol 103:541–549

    Article  Google Scholar 

  56. Lote K, Egeland T, Hager B, Stenwig B, Skullerud K, Berg-Johnsen J, Storm-Mathisen I, Hirschberg H (1997) Survival, prognostic factors and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol 15:3129–3140

    PubMed  CAS  Google Scholar 

  57. Olson JD, Riedel E, DeAngelis L (2000) Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54:1442–1448

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Talacchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Talacchi, A., d’Avella, D., Denaro, L. et al. Cognitive outcome as part and parcel of clinical outcome in brain tumor surgery. J Neurooncol 108, 327–332 (2012). https://doi.org/10.1007/s11060-012-0818-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-012-0818-3

Keywords

Navigation